RecruitingPHASE1, PHASE2NCT05956821

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

Studying Anaplastic astrocytoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Miami
Principal Investigator
Heather McCrea, MD
University of Miami
Intervention
SIACI of cetuximab and bevacizumab(drug)
Enrollment
20 enrolled
Eligibility
1-21 years · All sexes
Timeline
2025 – 2029

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05956821 on ClinicalTrials.gov

Other trials for Anaplastic astrocytoma

Additional recruiting or active studies for the same condition.

See all trials for Anaplastic astrocytoma →

← Back to all trials